Newsroom

latest news from ose
and across our portfolio

Featured News

Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive OfficerArticle links to www.beacontx.com
Beacon Therapeutics
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseasesArticle links to www.caristo.com
Caristo Diagnostics
Caristo Diagnostics Completes Series A Financing and Welcomes New CEOArticle links to quantummotion.tech
Quantum Motion Technologies
Quantum Motion Raises £42 Million Investment RoundArticle links to spybiotech.com
SpyBiotech
SpyBiotech Receives Grant from the Bill & Melinda Gates Foundation
Our 2022 HighlightsArticle links to innovation.ox.ac.uk
Oxford University retains No. 1 spot for spinouts
Oxford University retains No. 1 spot for spinoutsArticle links to www.ultromics.com
Ultromics
Ultromics granted FDA Breakthrough Device Designation

All News

Portfolio NewsNavenioBill Kloes joins Navenio as Chief Operating Officer to drive US expansionPortfolio NewsNavenioNavenio secures $12.6 million investment to accelerate global growth in healthcare and beyondPortfolio NewsNavenioNavenio and HERE Technologies to bring increased efficiency to indoor location & mapping with global partnership